P. Pearce

2.8k total citations · 1 hit paper
27 papers, 2.3k citations indexed

About

P. Pearce is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Molecular Biology. According to data from OpenAlex, P. Pearce has authored 27 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Genetics and 9 papers in Molecular Biology. Recurrent topics in P. Pearce's work include Estrogen and related hormone effects (12 papers), Hormonal Regulation and Hypertension (12 papers) and Ion Transport and Channel Regulation (4 papers). P. Pearce is often cited by papers focused on Estrogen and related hormone effects (12 papers), Hormonal Regulation and Hypertension (12 papers) and Ion Transport and Channel Regulation (4 papers). P. Pearce collaborates with scholars based in Australia, New Zealand and United States. P. Pearce's co-authors include John W. Funder, Roy E. Smith, A. Ian Smith, Zygmunt S. Krozowski, Johannes M. H. M. Reul, B. A. K. Khalid, L. P. Roy, Kathy Myles, Ian Barr and D. Healy and has published in prestigious journals such as Science, New England Journal of Medicine and The Journal of Immunology.

In The Last Decade

P. Pearce

27 papers receiving 2.2k citations

Hit Papers

Mineralocorticoid Action: Target Tissue Specificity Is En... 1988 2026 2000 2013 1988 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Pearce Australia 16 1.8k 685 515 419 385 27 2.3k
J W Funder Australia 20 703 0.4× 455 0.7× 222 0.4× 146 0.3× 240 0.6× 45 1.5k
Norman Fleischer United States 27 830 0.5× 767 1.1× 904 1.8× 527 1.3× 103 0.3× 50 2.1k
Antoine Martinez France 29 806 0.4× 1.2k 1.7× 580 1.1× 624 1.5× 96 0.2× 68 2.5k
Masafumi Haji Japan 21 627 0.3× 469 0.7× 139 0.3× 387 0.9× 133 0.3× 58 1.4k
Alessandro M. Capponi Switzerland 22 734 0.4× 785 1.1× 362 0.7× 246 0.6× 84 0.2× 55 1.6k
Toshio Kaneko Japan 25 552 0.3× 773 1.1× 368 0.7× 209 0.5× 54 0.1× 77 1.8k
Jan-Åke Gustafsson Sweden 20 352 0.2× 672 1.0× 114 0.2× 957 2.3× 159 0.4× 27 1.7k
W L Miller United States 15 817 0.4× 912 1.3× 139 0.3× 478 1.1× 34 0.1× 17 2.0k
Arnold J. Eisenfeld United States 24 481 0.3× 423 0.6× 56 0.1× 716 1.7× 163 0.4× 53 1.6k
A J Perlman United States 19 665 0.4× 399 0.6× 102 0.2× 348 0.8× 93 0.2× 22 1.4k

Countries citing papers authored by P. Pearce

Since Specialization
Citations

This map shows the geographic impact of P. Pearce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Pearce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Pearce more than expected).

Fields of papers citing papers by P. Pearce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Pearce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Pearce. The network helps show where P. Pearce may publish in the future.

Co-authorship network of co-authors of P. Pearce

This figure shows the co-authorship network connecting the top 25 collaborators of P. Pearce. A scholar is included among the top collaborators of P. Pearce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Pearce. P. Pearce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blackstein, Martin E., Charles L. Vogel, R. F. Ambinder, et al.. (1997). Phase II study of gemcltablne in patients with metastatic breast cancer. European Journal of Cancer. 33. S149–S149. 58 indexed citations
2.
Vollenhoven, Beverley, P. Pearce, Adrian C. Herington, & D. Healy. (1994). Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin‐releasing hormone agonist pretreated women. Clinical Endocrinology. 40(4). 537–544. 41 indexed citations
3.
Pearce, P., Kathy Myles, & John W. Funder. (1993). Oestrogen and progesterone receptor assays in breast tumours. The Medical Journal of Australia. 159(4). 227–231. 2 indexed citations
4.
Funder, John W., P. Pearce, Kathy Myles, & L. P. Roy. (1990). Apparent mineralocorticoid excess, pseudohypoaldosteronism, and urinary electrolyte excretion: toward a redefinition of mineralocorticoid action. The FASEB Journal. 4(14). 3234–3238. 90 indexed citations
5.
Reul, Johannes M. H. M., P. Pearce, John W. Funder, & Zygmunt S. Krozowski. (1989). Type I and Type II Corticosteroid Receptor Gene Expression in the Rat: Effect of Adrenalectomy and Dexamethasone Administration. Molecular Endocrinology. 3(10). 1674–1680. 160 indexed citations
6.
Pearce, P., et al.. (1989). VASCULAR TYPE I ALDOSTERONE BINDING SITES ARE PHYSIOLOGICAL MINERALOCORTICOID RECEPTORS. Endocrinology. 125(4). 2224–2226. 124 indexed citations
7.
Cauchi, M.N., Paul Compton, R. Hähnel, et al.. (1989). Identification of the major sources of error in estrogen receptor measurements for individual laboratories using both tissue and cytosol samples. European Journal of Cancer and Clinical Oncology. 25(7). 1079–1086. 5 indexed citations
8.
9.
Pearce, P. & John W. Funder. (1988). Steroid binding to cardiac Type I receptors. Journal of Hypertension. 6(4). S131–133. 16 indexed citations
10.
Pearce, P., et al.. (1987). HIGH AFFINITY ALDOSTERONE BINDING SITES (TYPE I RECEPTORS) IN RAT HEART. Clinical and Experimental Pharmacology and Physiology. 14(11-12). 859–866. 96 indexed citations
11.
Pearce, P. & John W. Funder. (1986). Cytosol and nuclear levels of thymic progesterone receptors in pregnant, pseudopregnant and steroid-treated rats. Journal of Steroid Biochemistry. 25(1). 65–69. 6 indexed citations
12.
Pearce, P., Margaret McNally, & John W. Funder. (1986). NUCLEAR LOCALIZATION OF TYPE 1 ALDOSTERONE BINDING SITES IN STEROID‐UNEXPOSED GH3 CELLS. Clinical and Experimental Pharmacology and Physiology. 13(9). 647–654. 14 indexed citations
13.
Armanini, Decio, Ursula Kuhnle, Thomas Strasser, et al.. (1985). Aldosterone-Receptor Deficiency in Pseudohypoaldosteronism. New England Journal of Medicine. 313(19). 1178–1181. 81 indexed citations
14.
Quinn, Michael, P. Pearce, Denys W. Fortune, et al.. (1985). Correlation between cytoplasmic steroid receptors and tumour differentiation and invasion in endometrial carcinoma. BJOG An International Journal of Obstetrics & Gynaecology. 92(4). 399–406. 12 indexed citations
15.
Barr, Ian, Kevin Pyke, P. Pearce, Ban‐Hock Toh, & J W Funder. (1984). Thymic sensitivity to sex hormones develops post-natally; an in vivo and an in vitro study.. The Journal of Immunology. 132(3). 1095–1099. 17 indexed citations
16.
Pearce, P., B. A. K. Khalid, & John W. Funder. (1983). Progesterone Receptors in Rat Thymus. Endocrinology. 113(4). 1287–1291. 46 indexed citations
17.
Khalid, B A, et al.. (1983). Dexamethasone induces different cellular protein synthetic responses in PNA+ and PNA- mouse thymocyte subpopulations.. The Journal of Immunology. 130(1). 115–120. 6 indexed citations
18.
Rae, Ian D., et al.. (1981). Mineralocorticoid activity of 21-deoxyaldosterone derivatives: Structure-function studies. Journal of Steroid Biochemistry. 14(10). 1041–1044. 2 indexed citations
19.
Weill, D, et al.. (1980). Intimal lesions in rat caudal artery. Ablation, replacement, and receptor studies on the protective effects of estrogen.. PubMed. 46(6 Pt 2). I103–5. 4 indexed citations
20.
Pearce, P. & John W. Funder. (1980). Glucocorticoid binding in mouse liver cytosol. Journal of Steroid Biochemistry. 13(12). 1493–1494. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026